These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17278986)

  • 21. Effect of medication burden on persistent use of lipid-lowering drugs among patients with hypertension.
    Robertson TA; Cooke CE; Wang J; Shaya FT; Lee HY
    Am J Manag Care; 2008 Nov; 14(11):710-6. PubMed ID: 18999905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort study.
    Roede BM; Bresser P; Bindels PJ; Kok A; Prins M; ter Riet G; Geskus RB; Herings RM; Prins JM
    Thorax; 2008 Nov; 63(11):968-73. PubMed ID: 18682520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood pressure control in patients initiating antihypertensive therapy.
    Weycker D; Edelsberg J; Vincze G; Levy DG; Kartashov A; Oster G
    Ann Pharmacother; 2008 Feb; 42(2):169-76. PubMed ID: 18182472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study.
    Hanon O; Berrou JP; Negre-Pages L; Goch JH; Nádházi Z; Petrella R; Sedefdjian A; Sévenier F; Shlyakhto EV; Pathak A
    J Hypertens; 2008 Aug; 26(8):1642-50. PubMed ID: 18622244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive drugs and new-onset diabetes: a retrospective longitudinal cohort study.
    Jong GP; Chang MH; Tien L; Li SY; Liou YS; Lung CH; Ma T
    Cardiovasc Ther; 2009; 27(3):159-63. PubMed ID: 19689614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generic substitution of antihypertensive drugs: does it affect adherence?
    Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
    Ann Pharmacother; 2006 Jan; 40(1):15-20. PubMed ID: 16303985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
    Patel BV; Remigio-Baker RA; Thiebaud P; Preblick R; Plauschinat C
    BMC Fam Pract; 2008 Nov; 9():61. PubMed ID: 18990240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
    Raum E; Lietzau S; Stegmaier C; Brenner H; Rothenbacher D
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):485-94. PubMed ID: 18383562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).
    Van der Niepen P; Woestenburg A; Brié H; Vancayzeele S; MacDonald K; Denhaerynck K; Lee C; Hermans C; Abraham I
    Ann Pharmacother; 2009 May; 43(5):849-61. PubMed ID: 19351876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
    Haywood LJ; Ford CE; Crow RS; Davis BR; Massie BM; Einhorn PT; Williard A;
    J Am Coll Cardiol; 2009 Nov; 54(22):2023-31. PubMed ID: 19926008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
    Chodick G; Shalev V; Gerber Y; Heymann AD; Silber H; Simah V; Kokia E
    Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do psychological attributes matter for adherence to antihypertensive medication? The Finnish Public Sector Cohort Study.
    Nabi H; Vahtera J; Singh-Manoux A; Pentti J; Oksanen T; Gimeno D; Elovainio M; Virtanen M; Klaukka T; Kivimaki M
    J Hypertens; 2008 Nov; 26(11):2236-43. PubMed ID: 18854766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
    Sever PS; Poulter NR; Dahlof B; Wedel H;
    J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of secondary preventive medications after the first attack of acute coronary syndrome.
    Salomaa V; Pääkkönen R; Hämäläinen H; Niemi M; Klaukka T
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):386-91. PubMed ID: 17568237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of antihypertensive drugs in three European countries.
    Nicotra F; Wettermark B; Sturkenboom MC; Parodi A; Bellocco R; Ekbom A; Merlino L; Leimanis A; Mancia G; Fored M; Corrao G
    J Hypertens; 2009 Sep; 27(9):1917-22. PubMed ID: 19506527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of oral antihypertensive medication preceding blood pressure elevation in hospitalized patients.
    de Macedo CR; Noblat AC; Noblat L; de Macedo JM; Lopes AA
    Arq Bras Cardiol; 2001 Oct; 77(4):324-31. PubMed ID: 11733801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rate and causes of infliximab discontinuation in patients with rheumatoid arthritis in a private clinical practice.
    Bertoli AM; Strusberg I; Baravalle M; Betelu Z; Calás D; Morales L; Strusberg AM
    J Clin Rheumatol; 2008 Dec; 14(6):313-7. PubMed ID: 18690164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming barriers: the role of providers in improving patient adherence to antihypertensive medications.
    Harmon G; Lefante J; Krousel-Wood M
    Curr Opin Cardiol; 2006 Jul; 21(4):310-5. PubMed ID: 16755199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.